Clinical Trials · NCT01969578
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Enrollment
- 149
- Start date
- Sep 2015
- Locations
- 26 sites, 8 countries
- Primary endpoint
- Progression Free Survival (PFS)